Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation

Vaccine

Volumn 31, Issue 3, 2013, Pages 495-499

  Murray, Gerald L ^a   Lo, Miranda ^a   Bulach, Dieter M ^a   Srikram, Amporn ^b,d   Seemann, Torsten ^a   Quinsey, Noelene S ^a   Sermswan, Rasana W ^b   Allen, Andy ^c   Adler, Ben ^a  

^a MONASH UNIVERSITY   (Australia)

^b KHON KAEN UNIVERSITY   (Thailand)

^c PFIZER INC   (United States)

^d KASETSART UNIVERSITY   (Thailand)

Author keywords

L. borgpetersenii; Protein expression; Reverse vaccinology; Serovar Hardjo; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DENATURATION; FEMALE; GENE SEQUENCE; HAMSTER; IMMUNE RESPONSE; IMMUNOGENICITY; LEPTOSPIRA; LEPTOSPIRA BORGPETERSENII; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PURIFICATION; RENAL PROTECTION; SEROTYPE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY DISEASES; LEPTOSPIRA; LEPTOSPIROSIS; MALE; MESOCRICETUS;

EID: 84871659155     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.028     Document Type: Article

References (41)

1. Hartskeerl R.A. International Leptospirosis Society: objectives and achievements. Rev Cubana Med Trop 2005, 57:7-10.
2. Adler B., de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010, 140:287-296.
3. Bharti A.R., Nally J.E., Ricaldi J.N., Matthias M.A., Diaz M.M., Lovett M.A., et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757-771.
4. Marotto P.C., Nascimento C.M., Eluf-Neto J., Marotto M.S., Andrade L., Sztajnbok J., et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999, 29:1561-1563.
5. Milner A.R., Wilks C.R., Calvert K. The prevalence of antibodies to members of Leptospira interrogans in cattle. Aust Vet J 1980, 56:327-330.
6. Faine S., Adler B., Bolin C., Perolat P. Leptospira and Leptospirosis 1999, MediSci, Australia.
7. Bolin C.A., Alt D.P. Use of a monovalent leptospiral vaccine to prevent renal colonization and urinary shedding in cattle exposed to Leptospira borgpetersenii serovar Hardjo. Am J Vet Res 2001, 62:995-1000.
8. Feigin R.D., Lobes L.A., Anderson D., Pickering L. Human leptospirosis from immunized dogs. Ann Intern Med 1973, 79:777-785.
9. Kemenes F. Cross-immunity studies on virulent strains of Leptospires belonging to different serotypes. Z Immunitats Allergieforsch 1964, 127:209-229.
10. Plesko I. Cross immunity relations among lipase positive and negative leptospiral strains. Biologia (Bratisl) 1974, 29:705-710.
11. Srikram A., Zhang K., Bartpho T., Lo M., Hoke D.E., Sermswan R.W., et al. Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant. J Infect Dis 2011, 203:870-879.
12. Haake D.A., Mazel M.K., McCoy A.M., Milward F., Chao G., Matsunaga J., et al. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 1999, 67:6572-6582.
13. Seixas F.K., da Silva E.F., Hartwig D.D., Cerqueira G.M., Amaral M., Fagundes M.Q., et al. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 2007, 26:88-95.
14. Silva E.F., Medeiros M.A., McBride A.J., Matsunaga J., Esteves G.S., Ramos J.G., et al. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 2007, 25:6277-6286.
15. Ren S.X., Fu G., Jiang X.G., Zeng R., Miao Y.G., Xu H., et al. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003, 422:888-893.
16. Bulach D.M., Zuerner R.L., Wilson P., Seemann T., McGrath A., Cullen P.A., et al. Genome reduction in Leptospira borgpetersenii reflects limited transmission potential. Proc Natl Acad Sci USA 2006, 103:14560-14565.
17. Felix S.R., Hartwig D.D., Argondizzo A.P., Silva E.F., Seixas F.K., Neto A.C., et al. Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin Vaccine Immunol 2011, 18:2026-2030.
18. Nascimento A.L., Ko A.I., Martins E.A., Monteiro-Vitorello C.B., Ho P.L., Haake D.A., et al. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J Bacteriol 2004, 186:2164-2172.
19. Picardeau M., Bulach D.M., Bouchier C., Zuerner R.L., Zidane N., Wilson P.J., et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS ONE 2008, 3:e1607.
20. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
21. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 2001, 305:567-580.
22. Juncker A.S., Willenbrock H., Von Heijne G., Brunak S., Nielsen H., Krogh A. Prediction of lipoprotein signal peptides in Gram-negative bacteria. Protein Sci 2003, 12:1652-1662.
23. Setubal J.C., Reis M., Matsunaga J., Haake D.A. Lipoprotein computational prediction in spirochaetal genomes. Microbiol 2006, 152:113-121.
24. Zhai Y., Saier M.H. A web-based program (WHAT) for the simultaneous prediction of hydropathy, amphipathicity, secondary structure and transmembrane topology for a single protein sequence. J Mol Microbiol Biotechnol 2001, 3:501-502.
25. Cullen P.A., Cordwell S.J., Bulach D.M., Haake D.A., Adler B. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect Immun 2002, 70:2311-2318.
26. Murray G.L., Srikram A., Henry R., Puapairoj A., Sermswan R.W., Adler B. Leptospira interrogans requires heme oxygenase for disease pathogenesis. Microbes Infect 2009, 11:311-314.
27. Zuerner R.L., Alt D.P., Palmer M.V. Development of chronic and acute golden Syrian hamster infection models with Leptospira borgpetersenii serovar Hardjo. Vet Pathol 2012, 49:403-411.
28. Yan W., Faisal S.M., McDonough S.P., Divers T.J., Barr S.C., Chang C.F., et al. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect 2009, 11:230-237.
29. Pizza M., Scarlato V., Masignani V., Giuliani M.M., Arico B., Comanducci M., et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-1820.
30. Maione D., Margarit I., Rinaudo C.D., Masignani V., Mora M., Scarselli M., et al. Identification of a universal Group B Streptococcus vaccine by multiple genome screen. Science 2005, 309:148-150.
31. Ross B.C., Czajkowski L., Hocking D., Margetts M., Webb E., Rothel L., et al. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine 2001, 19:4135-4142.
32. Wizemann T.M., Heinrichs J.H., Adamou J.E., Erwin A.L., Kunsch C., Choi G.H., et al. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 2001, 69:1593-1598.
33. Myers G.S., Parker D., Al-Hasani K., Kennan R.M., Seemann T., Ren Q., et al. Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus. Nat Biotechnol 2007, 25:569-575.
34. Etz H., Minh D.B., Henics T., Dryla A., Winkler B., Triska C., et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002, 99:6573-6578.
35. Deveson Lucas D.S., Cullen P.A., Lo M., Srikram A., Sermswan R., Adler B. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 2011, 29:3413-3418.
36. Brandt E.R., Hayman W.A., Currie B., Carapetis J., Wood Y., Jackson D.C., et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1996, 89:331-337.
37. Giuliani M.M., Adu-Bobie J., Comanducci M., Arico B., Savino S., Santini L., et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 2006, 103:10834-10839.
38. Jones D. Reverse vaccinology on the cusp. Nat Rev Drug Discov 2012, 11:175-176.
39. Cao X.J., Dai J., Xu H., Nie S., Chang X., Hu B.Y., et al. High-coverage proteome analysis reveals the first insight of protein modification systems in the pathogenic spirochete Leptospira interrogans. Cell Res 2010, 20:197-210.
40. Erdile L.F., Brandt M.A., Warakomski D.J., Westrack G.J., Sadziene A., Barbour A.G., et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun 1993, 61:81-90.
41. Cullen P.A., Lo M., Bulach D.M., Cordwell S.J., Adler B. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 2003, 49:18-29.